From April 17 to April 24, hospitals’ demand for the drug traditionally used to treat malaria fell 62 percent according to Vizient, a group purchasing organization.
A growing number of public health officials have warned against using the drug in COVID-19 patients until more data is available from clinical trials, according to STAT.
The FDA issued a warning last week about serious side effects of the drug, including heart rhythm problems.
The supply of hydroxychloroquine has increased as several drugmakers, including Bayer, Teva Pharmaceuticals and Novartis, have donated millions of pills to the Strategic National Stockpile, according to STAT.
Read the full article here.
More articles on pharmacy:
Top 15 specialty pharmacies by revenue
CVS to offer self-swab COVID-19 tests at 1,000 pharmacies
Walgreens to add COVID-19 testing sites in 49 states
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.